SUTRO BIOPHARMA INC (STRO) Stock Balance Sheet
NASDAQ:STRO • US8693672011
Current stock price
34.69 USD
+1.1 (+3.27%)
At close:
34.69 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 58.13M | 190.30M | 69.27M | 47.30M | 30.40M | |||
| Marketable Securities | 83.30M | 126.59M | 306.35M | 287.10M | 167.50M | |||
| Receivables | 3.98M | 8.62M | 36.08M | 7.10M | 12.50M | |||
| Other Current Assets | 5.52M | 17.80M | 9.85M | 11.70M | 8.10M | |||
| Total Current Assets | 150.93M | 343.31M | 421.54M | 353.20M | 218.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 21.55M | 35.87M | 44.76M | 51.10M | 51.60M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 68.80M | |||
| Other Non-Current Assets | 1.35M | 8.03M | 4.44M | 2.70M | 2.50M | |||
| Total Non-Current Assets | 22.90M | 43.90M | 49.19M | 53.70M | 122.90M | |||
| TOTAL ASSETS | 173.83M | 387.21M | 470.74M | 406.90M | 341.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 4.06M | 12.50M | 9.40M | |||
| Accrued Expenses | 57.01M | 51.63M | 59.58M | 32.50M | 12.50M | |||
| Accounts Payable | 7.57M | 10.47M | 9.44M | 4.80M | 11.30M | |||
| Other Current Liabilities | 10.56M | 69.78M | 20.67M | 16.80M | 8.60M | |||
| Total Current Liabilities | 75.13M | 131.89M | 93.75M | 66.50M | 41.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 3.80M | 15.70M | |||
| Other Non-Current Liabilities | 231.15M | 210.71M | 227.34M | 119.60M | 31.40M | |||
| Total Non-Current Liabilities | 231.15M | 210.71M | 227.34M | 123.40M | 47.10M | |||
| TOTAL LIABILITIES | 306.28M | 342.61M | 321.09M | 189.90M | 88.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -977.96M | -786.87M | -559.41M | -452.60M | -333.40M | |||
| Additional Paid In Capital | 845.48M | 831.35M | 708.98M | 670.20M | 586.20M | |||
| Common Shares | 9.00K | 83.00K | 61.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | 19.00K | 39.00K | 21.00K | -600.00K | -300.00K | |||
| Shares Outstanding | 8.58M | 8.25M | 6.10M | 5.75M | 4.64M | |||
| Tangible Book Value per Share | -15.43 | 5.40 | 24.53 | 3.77 | 5.44 | |||
| Total Shareholders' Equity | -132.45M | 44.60M | 149.65M | 217.00M | 252.60M | |||
| TOTAL LIABILITIES AND EQUITY | 173.83M | 387.21M | 470.74M | 406.90M | 341.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.02 | 0.06 | |||
| Current Ratio | 2.01 | 2.60 | 4.50 | 5.31 | 5.24 | |||
| Return On Assets (ROA) | -109.93% | -58.74% | -22.69% | -29.29% | -30.91% | |||
| Return On Equity (ROE) | N/A | -509.99% | -71.36% | -54.93% | -41.78% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21